Two Ways to Profit from Hims & Hers (HIMS) Stock

Hims & Hers (HIMS) shares have recently displayed heightened volatility and expanded liquidity, offering investors two distinct profit pathways. The first strategy leverages call options during low‑volatility periods to maximize upside potential, while the second employs a covered call approach to generate additional income while preserving the underlying position.

Call Options: Unlocking the Upside

■Long Call: Purchase a 30‑day call option with a strike price roughly 10% below the current HIMS price.

■Potential Return: If HIMS rises 15%‑20%, the option’s intrinsic value can surge, delivering a 200%‑250% percentage gain.

■Risk Management: The option premium is the maximum loss, limiting exposure to 5%‑7% of the total capital allocated.

■Time Decay: As expiration approaches, time value erodes; therefore, price movement must materialize close to the option’s maturity.

Covered Call: Passive Income Stream

■Position Initiation: Hold HIMS shares and sell a call option 5%‑10% out‑of‑the‑money, capturing the premium.

■Premium Yield: The collected premium can generate a 3%‑5% additional return if the stock remains flat or declines modestly.

■Profit/Loss Scenarios:

- If HIMS stays below the strike, the option expires worthless and the premium is pure profit.

■If HIMS exceeds the strike, the shares are called away; combined with the premium, investors typically realize a 8%‑12% total return.

■Limited Downside: Even in a sharp price drop, the premium provides a modest buffer.

Combining Both Strategies

■Layered Protection: Initiate a covered call, then buy a lower‑strike call to retain upside exposure while still earning premium.

■Balanced Risk/Reward: This hybrid approach blends premium income with potential option gains, smoothing overall portfolio volatility.

■Liquidity & Volatility Monitoring: HIMS’s daily volume and implied volatility (IV) directly affect option pricing; an IV range of 30%‑45% is generally optimal.

HIMS is a fast‑growing health‑tech firm with a growth‑centric roadmap, yet regulatory and competitive pressures can cause price swings. In this context, a directional long call and a covered‑call income strategy can be tailored to an investor’s risk appetite. Elevated volatility inflates option premiums, enhancing the allure of covered calls. Investors should closely track HIMS’s valuation metrics (P/E, EV/EBITDA) and clinical trial outcomes to fine‑tune the timing of their option plays.